Truist lifts US health insurer PTs on margin recovery prospects
BUZZ-Truist lifts US health insurer PTs on margin recovery prospects ** Truist Securities raises PTs on U.S. health insurers Centene CNC.N, CVS Health CVS.N, Elevance Health ELV.N, Humana HUM.N, Molina Healthcare MOH.N and UnitedHealth UNH.N, while keeping ratings unchanged
** Brokerage sees the sector "having several innings remaining of a longer-term earnings recovery opportunity across the government businesses"
** The S&P 500 Managed Health Care Sub-Industry Index .SPLRCHMO has gained 32.03% YTD, according to LSEG data
** Brokerage expects profits from government-backed plans to improve, supported by favorable 2027 Medicare rates and Medicaid margins likely bottoming in 2026 before recovering from 2027
** Truist also sees further growth in Affordable Care Act plans and manageable medical use, adding that insurers' 2026 cost and pricing forecasts appear conservative
** "We remain bullish on continued investment activity across the group in technology/automation/AI," Truist says
** Brokerage reiterates "buy" ratings on Cigna CI.N, CNC, CVS, ELV and UNH and "hold" for HUM and MOH
PT changes from Truist:
Company | New PT | Old PT |
CNC | $78 | $71 |
CVS | $118 | $108 |
ELV | $475 | $450 |
HUM | $415 | $320 |
MOH | $250 | $205 |
UNH | $480 | $440 |
(Reporting by Kunal Das in Bengaluru)
((Kunal.Das2@thomsonreuters.com;))
Recent news on Cigna group
See all newsBrief: Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits And Clinical Support Around Each Person, Improving Affordability And Outcomes
Most Americans support switch to Medicare for all health insurance
Analysis: Vance's fraud crackdown may raise costs for US health insurers, enrollees
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
US RESEARCH ROUNDUP-Arxis, Cigna, Vylor